Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

16 Jun 2006 07:00

Embargoed Release: 07:00hrs Friday 16th June 2006 SOPHEON PLC AGM Statement At the Annual General Meeting of Sopheon plc to be held later today, theChairman of the board will give shareholders an update on the business. Thiswill include the following statement:"We are almost at the end of the first half of 2006 and in this period we havehad steady and continued development in our business. In addition to businessgenerated in our traditional territories, we are pleased to report that we havesigned our second major Accolade sale in Scandinavia, and our first in France.Our teams in the US and Europe have been able to generate 50% moreimplementation and consulting services revenue by the end of May than in thesame period last year, thanks in part to management actions taken in the secondhalf of last year. New license wins and increased recurring maintenancerevenues - which now stand at ‚£1.6m annualized - along with the step up inservices business, has put the overall business on course to significantlyimprove on the first half of 2005. However, as always I would mention that ourperformance in any reporting period can be materially affected by the signaturedate of individual deals. This factor will be a continuing consideration as webuild the business, but one that should be increasingly offset by growth.The market for product life cycle management (PLM) applications continues toexpand, with analysts forecasting compound annual growth rates ranging from 8%to 11% through 2008. More importantly, during the same period, the PLMsubmarket in which Accolade has been classified is projected to triple in size.Sopheon's offering is well positioned to take advantage of this anticipatedescalation in demand. In 2005, we strengthened our market-share in thechemicals, paper and food & beverage industries, and they remain our principaltargets. But we have also enjoyed major successes with new clients in consumerpackaged goods markets, and recently expanded our sales and marketing effortsto target manufacturers in that sector.On the product front, we have invested in the creation of a new research andapplications development (RAD) team. Its charter is to create new softwareapplications that leverage the strength of the Accolade platform and providenew sources of revenue growth. We are pleased to announce the firstapplications produced by the RAD organization, which will be introduced to themarket in the third quarter of this year: * Accolade Product Roadmapping and Planning Application - this offering will enable companies to advance the maturity of their innovation processes by making it easier for them to develop and evaluate long-term product plans, manage programs or product "families", manage product relationships, and assess the impact of dependencies among projects during portfolio analysis. * New Versions of Accolade's Stage-Gate Process and Portfolio Management Applications - these enhanced versions of existing Accolade applications will introduce new best-practice models to further support portfolio planning and the post-launch stages of product life cycle management. One important benefit of our product strategy will be to further ourrelationships with existing clients, which accounted for a quarter ofnon-recurring revenues during 2005. We expect our partners to contribute to anincrease in lead activity and sales contracts during 2006 as our resellernetwork gains additional traction and our emerging relationships with selectglobal business-management consulting partners deepen. The importance ofSopheon's ongoing relationship with Microsoft was raised to a new level withour recent promotion to the elite status of "named" partner. This advancemententitles Sopheon to the support of a Microsoft business development managerdedicated to ensuring that we receive maximum business benefit from our accessto Microsoft technical, sales and marketing resources.Sopheon also announces that it has filed a certification with the US Securitiesand Exchange Commission ("SEC") on Form 15, to immediately suspend its duty tofile reports under the Securities Act of 1934. Sopheon will realize costsavings by no longer making these filings. The certification confirms, amongother points, that Sopheon has approximately 400 US resident shareholders.These shareholders represent less than 1% of the company's issued capital, andSopheon's ordinary shares are not traded in any US markets. Sopheon beganfiling reports with the SEC following its US registration of shares issued inconnection with the acquisition of Teltech Resource Network Corporation in2000. This change will have no effect on the trading of Sopheon's shares on AIMand Euronext.Finally, we wish to inform you that Andrew Davis, a non-executive director, isretiring from the board of Sopheon as from 30 June 2006, in order to focus onhis other interests. The directors and staff thank him for his contribution tothe development of the group. This brings the overall size of the Sopheon boardto six, comprising three executive and three non-executive directors."For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Frank Jansen Citigate First Financial Tel : + 31 (0) 205 75 40 24 About SopheonSopheon (LSE:SPE) is an international provider of software and services thathelp organizations improve the business impact of product innovation. TheSopheon Accolade‚® system automates gate or phase-based product developmentprocesses and provides strategic decision support that allows companies toincrease revenue and profits from new products. Sopheon is listed on the AIMMarket of the London Stock Exchange and on the Euronext in the Netherlands. Formore information, please visit www.sopheon.com.ENDSOPHEON PLC
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.